why choose us

First received: June 14, 2023

Clinical Trial: Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Islet Transplantation

Study Type: INTERVENTIONAL


Official Title: Clinical Islet Transplantation With Apheresis, Isolation and Reintroduction of Recipient Regulatory T Cells or Administration of Deceased Donor Vertebral Bone Marrow in Type 1 Diabetes

Brief Summary: The goal of this clinical trial is to learn if patients who have brittle type 1 diabetes receiving an islet transplantation will have better control of their sugars if they also receive one of 2 types of immune cells along with the islet transplant.The participants will receive either their own immune cells, called regulatory T cells, or immune cells from the bone marrow of the islet donor.

Read more